REFERENCES
- Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425–432
- Bonnet M, Delavaud C, Laud K, et al. Mammary leptin synthesis, milk leptin and their putative physiological roles. Reprod Nutr Dev 2002; 42: 399–413
- Bonnet M, Gourdou I, Leroux C, Chilliard Y, Djiane J. Leptin expression in the ovine mammary gland: putative sequential involvement of adipose, epithelial, and myoepithelial cells during pregnancy and lactation. J Anim Sci. 2002; 80: 723–728
- Laud K, Gourdou I, Belair L, Keisler DH, Djiane J. Detection and regulation of leptin receptor mRNA in ovine mammary epithelial cells during pregnancy and lactation. FEBS Lett 1999; 463: 194–198
- Smith JL, Sheffield LG. Production and regulation of leptin in bovine mammary epithelial cells. Domest Anim Endocrinol 2002; 22: 145–154
- Smith-Kirwin SM, O'Connor DM, De Johnston J, Lancey ED, Hassink SG, Funanage VL. Leptin expression in human mammary epithelial cells and breast milk. J Clin Endocrinol Metab 1998; 83: 1810–1813
- Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery R, Giudicelli Y. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2002; 293: 622–628
- Hu X, Juneja SC, Maihle NJ, Cleary MP. Leptin—a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 2002; 94: 1704–1711
- Laud K, Gourdou I, Pessemesse L, Peyrat JP, Djiane J. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 2002; 188: 219–226
- Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763–770
- Houseknecht KL, Baile CA, Matteri RL, Spurlock ME. The biology of leptin: a review. J Anim Sci 1998; 76: 1405–1420
- Caldefie-Chezet F, Damez M, de Latour M, et al. Leptin: a proliferative factor for breast cancer? Study on human ductal carcinoma. Biochem Biophys Res Commun 2005; 334: 737–741
- Mantzoros CS, Bolhke K, Moschos S, Cramer DW. Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int J Cancer 1999; 80: 523–526
- Tessitore L, Vizio B, Jenkins O, et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 2000; 5: 421–426
- Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res, 10: 4325–4331
- O'Brien SN, Welter BH, Price TM. Presence of leptin in breast cell lines and breast tumors. Biochem Biophys Res Commun 1999; 259: 695–698
- Sheffield LG. C-Src activation by ErbB2 leads to attachment-independent growth of human breast epithelial cells. Biochem Biophys Res Commun 1998; 250: 27–31
- Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999; 270: 41–49
- Yuan JS, Reed A, Chen F, Stewart CN, Jr. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006; 7: 85
- Vanderboom RJ, Sheffield LG. Estrogen enhances epidermal growth factor-induced DNA synthesis in mammary epithelial cells. J Cell Physiol 1993; 156: 367–372
- Gill JL. Design and Analysis of Experiments in the Animal and Medical Sciences. Iowa State University Press, Iowa City, IA 1978
- Sayed-Ahmed A, Kulcsar M, Rudas P, Bartha T. Expression and localisation of leptin and leptin receptor in the mammary gland of the dry and lactating non-pregnant cow. Acta Vet Hung 2004; 52: 97–111
- Danielsen AJ, Maihle NJ. The EGF/ErbB receptor family and apoptosis. Growth Factors 2000; 20: 1–15
- Dickson RB, Salomon DS, Lippman ME. Tyrosine kinase receptor—nuclear protooncogene interactions in breast cancer. Cancer Treat Res 1992; 61: 249–273
- Ernberg IT. Oncogenes and tumor growth factors in breast cancer. A minireview. Acta Oncol 1990; 29: 331–334
- Lo HW, Hsu SC, Hung MC. EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat 2006; 95: 211–218
- Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF I, II, Hynes NE. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci USA 2003; 100: 8933–8938
- Hudelist G, Singer CF, Manavi M, Pischinger K, Kubista E, Czerwenka K. Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors. Breast Cancer Res Treat 2003; 80: 353–361
- Roskoski R, Jr. The ErbB/HER receptor protein-tyrosine kinases and cancer. Biochem Biophys Res Commun. 2004; 319: 1–11
- Rubin I, Yarden Y. The basic biology of HER2. Ann Oncol 2001; 12(suppl 1)S3–S8
- Kloek C, Haq AK, Dunn SL, Lavery HJ, Banks AS, Myers MG, Jr. Regulation of Jak kinases by intracellular leptin receptor sequences. J Biol Chem 2002; 277: 41547–41555
- Myers MG, Jr. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog Horm Res 2004; 59: 287–304
- Bjorbaek C, Uotani S, da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 1997; 272: 32686–32695